Company Filing History:
Years Active: 2000-2008
Title: The Innovative Contributions of Deborah Fass
Introduction
Deborah Fass is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical research, particularly in the study of HIV. With a total of 3 patents, her work has been instrumental in advancing our understanding of viral mechanisms and potential therapeutic interventions.
Latest Patents
One of her latest patents focuses on the core structure of gp41 from the HIV envelope glycoprotein. This patent describes the crystal structure of the α-helical domain of the gp41 component of HIV-1 envelope glycoprotein, which represents the core of fusion-active gp41. The patent outlines methods for identifying and designing drugs that inhibit gp41 function, as well as the drugs themselves. This innovative work is crucial for developing effective treatments against HIV.
Career Highlights
Deborah Fass is affiliated with the Whitehead Institute for Biomedical Research, where she conducts her research. Her career has been marked by a commitment to understanding complex biological systems and developing solutions to combat viral infections. Her expertise in structural biology and drug design has positioned her as a leader in her field.
Collaborations
Throughout her career, Deborah has collaborated with notable scientists, including David C. Chan and Min Lu. These collaborations have enriched her research and contributed to the advancement of knowledge in the biomedical community.
Conclusion
Deborah Fass's innovative work and dedication to HIV research exemplify the impact of scientific inquiry on public health. Her patents and collaborations highlight her role as a key figure in the fight against viral diseases.